Response to IFNα in myelogenous leukaemia [5]

Lancet

Volumn 347, Issue 8993, 1996, Pages 57-58

  Mahon, F X ^a   Faberes, C ^a   Reiffers, J ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADOLESCENT; ADULT; AGED; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030071402     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)91588-3     Document Type: Letter

References (4)

1. Hm Kantarjian Tl Smith S. O'Brien Prolonged survival in chronic myelogenous leukemia following cytogenetic response to alpha interferon therapy Ann Intern Med 122 1995 254 261
2. K. Ohnishi R. Ohno M. Tomonoga A randomized trial comparing Interferon-α with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase Blood 86 1995 906 916
3. Mm Horovitz D. Przepiorka Re Champlin Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood 79 1992 2771 2774
4. Hs Luft Jp Bunker Ac Enthoven Should operations be regionalized? The empirical relations between surgical volume and mortality N Engl J Med 301 1979 1364 1369